AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $129,000 | -62.1% | 44,901 | -50.0% | 0.00% | -100.0% |
| Q2 2021 | $340,000 | +466.7% | 89,793 | +403.3% | 0.00% | – |
| Q1 2021 | $60,000 | -61.0% | 17,841 | -67.4% | 0.00% | – |
| Q4 2020 | $154,000 | +234.8% | 54,712 | +197.3% | 0.00% | – |
| Q3 2020 | $46,000 | -89.8% | 18,400 | -44.7% | 0.00% | -100.0% |
| Q2 2020 | $452,000 | +59.7% | 33,300 | -11.0% | 0.00% | +50.0% |
| Q1 2020 | $283,000 | +444.2% | 37,400 | +255.9% | 0.00% | – |
| Q2 2019 | $52,000 | -62.3% | 10,510 | -27.5% | 0.00% | -100.0% |
| Q1 2018 | $138,000 | +1433.3% | 14,500 | +1379.6% | 0.00% | – |
| Q3 2015 | $9,000 | – | 980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |